North America Oligonucleotide Synthesis Market to 2027 - Regional Analysis and Forecasts by Product (Synthesized Oligonucleotides, Reagents, and Equipment), Application (Research, Diagnostics, and Therapeutics), End User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Other End Users)
- THE3312660
- 134 Pages
- October 2019
- Diagnostic and Biotech
The growth of the oligonucleotide Synthesis market is primarily attributed to the rising investments in the development of pharmaceutical and biotechnology companies. However, the growth of the market is restrained by factors such as renewed regulations for biotechnology and lack of skilled professionals in life science industry. On the other hand, rising investments by pharmaceutical and biotechnology companies is likely to have a positive impact on the growth of the North America Oligonucleotide Synthesis market in the coming years.
Advancement in the field of biotechnology has equally enhanced the synthetic biology. Many industry players have come up with innovative types of synthetic biology in last few years. Synthetic biology is a multidisciplinary approach that use various tools and techniques of biotechnology to alter the biological systems. The techniques such as cloning, gene sequencing, genome engineering has results into the generation of genetically modified organisms. The advancement in the synthetic biology has led to the faster and easier design of DNA, and helped exponentially reducing the cost of DNA sequencing and synthesis.
For instance, Twist Bioscience has developed Oligo pools, high diversity collections of oligonucleotides, are utilized in many applications, including generation of CRISPR guide RNA (sgRNA) libraries and high-throughput reporter assays. It offers precise editing of target loci as it enables highly accurate synthesis for specific targeting and the error rate is very low around 1:1000 nt. The company’s low synthesis error rate and uniform sequence representation result in high quality custom oligo libraries that enable the most efficient CRISPR screens.
In 2016, according to an annual industry growth update published by SynBioBeta, a leading community of investors, entrepreneurs, and others, more than US$ 1 Bn was invested in synthetic biology by various companies in the US and worldwide. Additionally, according a report by National Center for Biotechnology Information (NCBI), US government offers approximately US$220 million every year toward synthetic biology research and development. Moreover, Defense Advanced Research Projects Agency (DARPA) also offers funds for research in synthetic biology funding. For instance, DARPA has invested nearly US$110 million for synthetic biology in 2014.
In 2018, the synthesized oligonucleotides segment held a largest market share of 48.5% of the oligonucleotide synthesis market, by product. This segment is also expected to dominate the market in 2027 owing to increasing use of the product in research and diagnostic purposes. The segment is also anticipated to witness the growth at a significant rate during the forecast period, 2018 to 2027.
In 2018, the academic research institutes segment held a largest market share of 45.4% of the oligonucleotide synthesis market, by end user. This segment is also expected to dominate the market in 2027. However, the diagnostic laboratories segment is anticipated to witness the fastest growth rate of 12.3% during the forecast period. This higher growth rate of the segment can be attributed to the efficiency of oligonucleotides for diagnostic process.
In 2018, the reagent segment held a largest market share of 45.4% of the oligonucleotide synthesis market, by application. This segment is also expected to dominate the market in 2027 owing to availability of funds as well as supportive government policies. The segment is also anticipated to witness the growth at a significant rate during the forecast period, 2018 to 2027.
Some of the major primary and secondary sources for western blotting included in the report are, Centers for Disease Control and Prevention (CDC), Canadian Institutes of Health Research (CIHR), Association for Responsible Research and Innovation in Genome Editing (ARRIGE), Biotechnology and Biological Sciences Research Council (BBSRC), Genetically Modified Crops and Organisms (GMOs), Cancer Genomics and Advanced Therapeutics (C-CAT) and others.
1. Introduction
1.1 Scope Of The Study
1.2 The Insight Partners Research Report Guidance
2. North America Oligonucleotide Synthesis Market - Key Takeaways
3. North America Oligonucleotide Synthesis Market - Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 North America Oligonucleotide Synthesis Market - By Product
3.2.2 North America Oligonucleotide Synthesis Market - By Application
3.2.3 North America Oligonucleotide Synthesis Market - By End User
3.2.4 North America Oligonucleotide Synthesis Market - By Country
3.3 PEST Analysis
3.3.1 North America - PEST Analysis
4. North America Oligonucleotide Synthesis Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Rising adoption of Synthesized Oligonucleotides to Treat Medical Conditions
4.1.2 Technological Advancements in Synthetic Biology
4.1.3 Growing Investments by Private Players in Synthetic Biology
4.2 Key Market Restraints
4.2.1 Renewed Policies for Biotechnology Industry
4.2.2 Biotechnology Lacks Skilled Professionals
4.3 Key Market Opportunities
4.3.1 Collaborations — The Future of Innovation
4.4 Future Trends
4.4.1 New Product Developments in Synthetic Biology
4.5 Impact Analysis
5. Oligonucleotide Synthesis - North America Analysis
5.1 North America Oligonucleotide Synthesis Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Performance of Key Players
5.3.1 Thermo Fisher Scientific Inc.
5.3.2 GenScript
5.4 Expert Opinions
6. North America Oligonucleotide Synthesis Market Analysis -By Product
6.1 Overview
6.2 North America Oligonucleotide Synthesis Market, By Product, 2018 & 2027 (%)
6.3 Synthesized Oligonucleotides Market
6.3.1 Overview
6.3.2 North America Synthesized Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.3 Primers Market
6.3.3.1 Overview
6.3.3.2 North America Primers Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.4 Probes Market
6.3.4.1 Overview
6.3.4.1.1 North America Probes Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.4.2 Large-Scale Synthesis Oligonucleotides Market
6.3.4.2.1 Overview
6.3.4.2.2 North America Large-Scale Synthesis Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.4.3 Others Market
6.3.4.3.1 Overview
6.3.4.3.2 North America Others Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
6.4 Reagents Market
6.4.1 Overview
6.4.2 North America Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 Equipment Market
6.5.1 Overview
6.5.2 North America Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
7. North America Oligonucleotide Synthesis Market Analysis -By Application
7.1 Overview
7.2 North America Oligonucleotide Synthesis Market, By Application, 2018 & 2027 (%)
7.3 Research Market
7.3.1 Overview
7.3.2 North America Research Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Diagnostics Market
7.4.1 Overview
7.4.2 North America Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Therapeutics Market
7.5.1 Overview
7.5.2 North America Therapeutics Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
8. North America Oligonucleotide Synthesis Market Analysis -By End User
8.1 Overview
8.2 North America Oligonucleotide Synthesis Market, By End User, 2018 & 2027 (%)
8.3 Academic Research Institutes Market
8.3.1 Overview
8.3.2 North America Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Diagnostic Laboratories Market
8.4.1 Overview
8.4.2 North America Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Pharmaceutical & Biotechnology Companies Market
8.5.1 Overview
8.5.2 North America Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Other End Users Market
8.6.1 Overview
8.6.2 North America Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Oligonucleotide Synthesis Market Revenue And Forecasts To 2027
9.1 Overview
9.1.1 North America Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.2 North America Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.2.1 North America Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.3 North America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.4 North America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.5 North America Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)
9.1.6 US Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.1 US Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.2 US Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.6.2.1 US Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.6.3 US Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.6.4 US Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.7 Canada Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 Canada Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 Canada Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.7.2.1 Canada Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.3 Canada Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.7.4 Canada Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.8 Mexico Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.1 Mexico Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.2 Mexico Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.8.2.1 Mexico Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.8.3 Mexico Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.8.4 Mexico Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10. Oligonucleotide Synthesis Market -Industry Landscape
10.1 Overview
10.2 Comparative Company Analysis
10.3 Growth Strategies Done By the Companies in the Market, (%)
10.4 Organic Developments
10.4.1 Overview
10.5 Inorganic Developments
10.5.1 Overview
11. Oligonucleotide Synthesis Market-Key Company Profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 GenScript
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Synthomics, Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Ansa Biotechnologies, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Iridia, Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Helixworks
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial overview
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Keasling Lab
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Molecular Assemblies
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Twist Bioscience
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Evonetix
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial overview
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 DNA Script
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Financial overview
11.11.4 Product Portfolio
11.11.5 SWOT Analysis
11.11.6 Key Developments
11.12 Nuclera Nucleics Ltd.
11.12.1 Key Facts
11.12.2 Business Description
11.12.3 Financial Overview
11.12.4 Product Portfolio
11.12.5 SWOT Analysis
11.12.6 Key Developments
11.13 Camena Bio
11.13.1 Key Facts
11.13.2 Business Description
11.13.3 Financial Overview
11.13.4 Product Portfolio
11.13.5 SWOT Analysis
11.13.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary Of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research
Table 1. North America Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 2. North America Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 3. North America Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 4. North America Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 5. US Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 6. US Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 7. US Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 8. US Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 9. Canada Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 10. Canada Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 11. Canada Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 12. Canada Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 13. Mexico Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 14. Mexico Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 15. Mexico Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 16. Mexico Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 17. Organic Developments Done By Companies
Table 18. Inorganic Developments Done By Companies
Table 19. Glossary Of Terms, Oligonucleotide Synthesis Market
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
